中外医疗
中外醫療
중외의료
China Foreign Medical Treatment
2015年
27期
115-116
,共2页
沙丁胺醇%氨溴索%雾化%慢性阻塞性肺疾病%急性发作
沙丁胺醇%氨溴索%霧化%慢性阻塞性肺疾病%急性髮作
사정알순%안추색%무화%만성조새성폐질병%급성발작
Salbutamol atomization%Ambroxol%Chronic obstructive pulmonary disease%Acute exacerbation
目的 分析沙丁胺醇联合氨溴索雾化吸入治疗慢性阻塞性肺疾病急性发作的效果. 方法 整群选择该院呼吸内科2013年5 月-2015 年 5月的慢性阻塞性肺疾病急性发作住院患者190例,随机分为对照组和观察组各95例,对照组给予化痰解痉平喘、低流量吸氧和控制感染等常规基础治疗;在常规治疗基础上对观察组采用沙丁胺醇联合氨溴索雾化吸入治疗,两组的疗程都为 10 d. 分别观察治疗前后两组患者的各项肺功能指标,并对两组的临床疗效进行比较分析. 结果 治疗前两组患者的肺功能指标FEV1 、FVC 水平和 FEV1/FVC,P>0.05;治疗后两组患者 FEV1和 FEV1/FVC 水平均较治疗前有不同程度的提升,且观察组提升程度优于对照组,观察组FEV1 、FVC 水平和 FEV1/FVC 均高于对照组,P<0.05;临床疗效总有效率(92.6%)明显优于对照组(75.8%). 结论 沙丁胺醇联合氨溴索雾化吸入疗法可迅速缓解患者呼吸系统症状,有效改善慢性阻塞性肺疾病急性发作患者的肺功能.
目的 分析沙丁胺醇聯閤氨溴索霧化吸入治療慢性阻塞性肺疾病急性髮作的效果. 方法 整群選擇該院呼吸內科2013年5 月-2015 年 5月的慢性阻塞性肺疾病急性髮作住院患者190例,隨機分為對照組和觀察組各95例,對照組給予化痰解痙平喘、低流量吸氧和控製感染等常規基礎治療;在常規治療基礎上對觀察組採用沙丁胺醇聯閤氨溴索霧化吸入治療,兩組的療程都為 10 d. 分彆觀察治療前後兩組患者的各項肺功能指標,併對兩組的臨床療效進行比較分析. 結果 治療前兩組患者的肺功能指標FEV1 、FVC 水平和 FEV1/FVC,P>0.05;治療後兩組患者 FEV1和 FEV1/FVC 水平均較治療前有不同程度的提升,且觀察組提升程度優于對照組,觀察組FEV1 、FVC 水平和 FEV1/FVC 均高于對照組,P<0.05;臨床療效總有效率(92.6%)明顯優于對照組(75.8%). 結論 沙丁胺醇聯閤氨溴索霧化吸入療法可迅速緩解患者呼吸繫統癥狀,有效改善慢性阻塞性肺疾病急性髮作患者的肺功能.
목적 분석사정알순연합안추색무화흡입치료만성조새성폐질병급성발작적효과. 방법 정군선택해원호흡내과2013년5 월-2015 년 5월적만성조새성폐질병급성발작주원환자190례,수궤분위대조조화관찰조각95례,대조조급여화담해경평천、저류량흡양화공제감염등상규기출치료;재상규치료기출상대관찰조채용사정알순연합안추색무화흡입치료,량조적료정도위 10 d. 분별관찰치료전후량조환자적각항폐공능지표,병대량조적림상료효진행비교분석. 결과 치료전량조환자적폐공능지표FEV1 、FVC 수평화 FEV1/FVC,P>0.05;치료후량조환자 FEV1화 FEV1/FVC 수평균교치료전유불동정도적제승,차관찰조제승정도우우대조조,관찰조FEV1 、FVC 수평화 FEV1/FVC 균고우대조조,P<0.05;림상료효총유효솔(92.6%)명현우우대조조(75.8%). 결론 사정알순연합안추색무화흡입요법가신속완해환자호흡계통증상,유효개선만성조새성폐질병급성발작환자적폐공능.
Objective To observe the effect of salbutamol combined with ambroxol inhalation in treatment of acute exacerbation of chronic obstructive pulmonary disease. Methods Choose in respiratory department of our hospital, During May 2013 to May 2015 in chronic obstructive lung disease acute episodes of hospitalization patients, 190 cases, were randomly assigned to control group and observation group, each group of 95 cases. Patients in the control group were treated by low flow oxygen, eliminating phlegm and relieving asthma, control infection and other routine treatment; observation group in the conventional treatment on the basis of using salbutamol and Ambroxol Aerosol Inhalation. Two groups of treatment for 10 days. The pulmonary function index of the two groups were observed, and the clinical effect of the two groups were compared. Results In the treatment of two groups of patients lung function index FEV1, FVC and FEV1/FVC (P<0.05). The two groups of patients with FEV1 and FEV1/FVC levels before and after treatment had different degrees of improvement and the observation group to enhance the degree of the superior to the control group and observation group, FEV1, FVC and FEV1/FVC were higher than the control group (P<0.05). Clinical curative effect of total efficiency (92.6%) was significantly better than the control group (75.8%). Conclusion Salbutamol and Ambroxol Aerosol Inhalation can effectively improve the pulmonary function in treatment of patients with acute exacerbation of chronic ob-structive pulmonary disease, quickly alleviate the symptoms of respiratory system.
